SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001078782-18-000452
Filing Date
2018-04-18
Accepted
2018-04-18 16:46:15
Documents
4
Period of Report
2018-03-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K CURRENT REPORT f8k041818_8k.htm 8-K 20770
2 EXHIBIT 1.1 STOCK PURCHASE AGREEMENT BY AND BETWEEN CROSS & COMPANY AND AXIM f8k041818_ex1z1.htm EX-1.1 33161
3 EXHIBIT 5.1 OPINION OF PROCOPIO, CORY, HARGREAVES & SAVITCH f8k041818_ex5z1.htm EX-5.1 8527
4 IMAGE f8k041818_ex5z11.jpg GRAPHIC 33315
  Complete submission text file 0001078782-18-000452.txt   109158
Mailing Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022
Business Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54296 | Film No.: 18761594
SIC: 2834 Pharmaceutical Preparations